91Ӱ

Lipid News

Don’t game the system — be the system

Binks Wattenberg
Oct. 1, 2016

Who here is tired of exchanging tales of woe about grants not funded? Most of us, I suspect. Here I will describe how a group came together to develop a plan to give lipid-related grants a fair shake while we work to increase overall funding.

Lipid researchers often feel that their grants get dinged because of a lack of expertise in lipid biology in study sections. We know that when you are an expert in a field, you have a greater appreciation for the contributions that a particular grant can make to advance the field. With this in mind, colleagues and I started an initiative to ensure that grants with a lipid focus get the expert review that they (and all grants, really) deserve.

It is lost in the mists of time exactly when and where the idea nucleated, who was there, and why I could never get the hang of the secret handshake. But in time, a notion congealed — like a vat of warm triglyceride cooling in the breeze — that instead of kvetching about the lack of lipid expertise on the study sections, the lipid community could have a role in helping provide that expertise to the National Institutes of Health and other granting bodies.

And so the Lipid Research Division, or LRD (pronounced “lard,” of course), was born. Here, I will focus on how we have leveraged the LRD to help with grant review. The effort showcases how the LRD serves as an important voice for the lipid community within the 91Ӱ and Molecular Biology.

The first step was to establish a membership. The staff of the 91Ӱhas been phenomenal throughout this process, both in welcoming the LRD as part of the 91Ӱand in providing the information technology expertise and access to their membership database that were essential. We queried the 91Ӱmembership for interest in joining the LRD and also included non-91Ӱmembers to lasso them into the 91Ӱfold. We established an LRD membership list of several hundred members.

The next step was crucial. We engaged with staffers at the Center for Scientific Review at the NIH. Our pitch was simple: We want to help provide expertise, not push for more funding for lipid grants.

Several LRD steering committee members already had informally spoken with study-section scientific review officers to see if they were receptive to getting suggestions for lipid-centric reviewers. The response was overwhelmingly positive. SROs have so much to deal with. Imagine having to tell a study section full of caffeine junkies that coffee would no longer be available at the meetings. Horrors! Only slightly less onerous is ensuring that each study section is populated by the requisite expertise to review 80 grants on diverse topics using a variety of techniques. SROs do heroic duty by attending national meetings, going through meeting programs, looking through the literature and querying their contacts. They were glad for the help.

Encouraged, we went right to the top, speaking with Richard Nakamura, who is the director of CSR. He thought the idea was sound and guided us as to the qualifications they look for in reviewers and what information they could use that would help SROs find the expertise they need.

With the help of Ed Marklin, the IT wizard at the ASBMB, we used the awesome power of Survey Monkey to see who in the LRD fit the CRS’s criteria. Close to 50 of the LRD membership had NIH-eligible reviewing experience but currently were not serving. This was a treasure trove of potential lipid expertise. We transmitted the list to one of Nakamura’s advisers at the CSR, Christine Melchior, who since has customized the list for SROs for whom she is responsible.

We are not done. We also are thinking of granting bodies outside of the NIH, such as the National Science Foundation, Department of Defense and disease-specific foundations, that could use our list. We also know there are lipid experts out there who are eluding their NIH duties. We are tracking them down.

Which brings me to my last point, which is about participating in NIH review. The review process is only as good as the reviewers who wade through the grants. If an SRO invites you to review, even though you absolutely do not have the time, make some. Give up sleeping or eating: There is plenty of time for that after you retire. See you at study section. I will bring the coffee.

Enjoy reading 91ӰToday?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Binks Wattenberg

Binks Wattenberg is a professor in the department of biochemistry and molecular biology at Virginia Commonwealth University and a member of the 91ӰToday editorial advisory board.

Get the latest from 91ӰToday

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson’s fight for survival and hope. Without funding, science can’t “catch up” to help the patients who need it most.

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
News

Cracking cancer’s code through functional connections

July 2, 2025

A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.